Humana (HUM) Notes Payables (2009 - 2026)

Humana (HUM) has reported Notes Payables for 18 consecutive years, with $351.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Notes Payables rose 17.79% year-over-year to $351.0 million in Q2 2026; TTM through Jun 2026 was $351.0 million, a 17.79% increase from a year earlier, with the FY2025 full-year figure at $306.0 million, down 24.07% from the prior year.
• Notes Payables was $351.0 million for Q2 2026 at Humana, up from $297.0 million in the prior quarter.
• Over five years, Notes Payables peaked at $457.0 million in Q2 2023 and troughed at $237.0 million in Q3 2022.
• A 5-year average of $337.9 million and a median of $342.0 million in 2024 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables soared 65.68% in 2022 and fell 24.07% in 2025, its largest moves.
• Over 5 years, Notes Payables stood at $298.0 million in 2022, then gained by 18.46% to $353.0 million in 2023, then gained by 14.16% to $403.0 million in 2024, then declined by 24.07% to $306.0 million in 2025, then gained by 14.71% to $351.0 million in 2026.
• The last three Notes Payables figures came in at $351.0 million (Q2 2026), $297.0 million (Q1 2026), and $306.0 million (Q4 2025), per Business Quant data.